HAKEEM ADENIYI: Open Payments
NPI 1598083164 · VALLEJO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$243 in 10 payments from 9 companies in 2025. Trend: 2023 $239 · 2024 $252 · 2025 $243
Food & beverage: $243
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $53 |
| Gilead Sciences, Inc. | 1 | $34 |
| Exact Sciences Corporation | 1 | $28 |
| ABBVIE INC. | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $27 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
| Phadia US Inc. | 1 | $15 |
Products named: Wegovy, MAVYRET, AREXVY, INGREZZA, Rybelsus, ROTATEQ, INVEGA SUSTENNA, ImmunoCAP.
Industry payments across CA — which companies pay providers there.
